CN101869220A - Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome - Google Patents
Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome Download PDFInfo
- Publication number
- CN101869220A CN101869220A CN201010194664A CN201010194664A CN101869220A CN 101869220 A CN101869220 A CN 101869220A CN 201010194664 A CN201010194664 A CN 201010194664A CN 201010194664 A CN201010194664 A CN 201010194664A CN 101869220 A CN101869220 A CN 101869220A
- Authority
- CN
- China
- Prior art keywords
- parts
- additive
- herbal medicine
- pigs
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000411851 herbal medicine Species 0.000 title claims abstract description 94
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 38
- 208000021760 high fever Diseases 0.000 title claims abstract description 33
- 241000282898 Sus scrofa Species 0.000 title abstract description 93
- 241000282887 Suidae Species 0.000 claims abstract description 94
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 27
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 27
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 27
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 27
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 27
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 27
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 27
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 27
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 27
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 27
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 239000003674 animal food additive Substances 0.000 claims description 66
- 239000000654 additive Substances 0.000 claims description 36
- 230000000996 additive effect Effects 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 32
- 241001092040 Crataegus Species 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 21
- 244000061520 Angelica archangelica Species 0.000 claims description 18
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 14
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 241000206469 Pulsatilla Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 235000001405 Artemisia annua Nutrition 0.000 claims description 9
- 240000000011 Artemisia annua Species 0.000 claims description 9
- 241000007126 Codonopsis pilosula Species 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000382455 Angelica sinensis Species 0.000 claims description 8
- 244000236658 Paeonia lactiflora Species 0.000 claims description 8
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 7
- 244000197580 Poria cocos Species 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 235000008216 herbs Nutrition 0.000 claims 2
- 230000006870 function Effects 0.000 abstract description 17
- 230000034994 death Effects 0.000 abstract description 14
- 241001673966 Magnolia officinalis Species 0.000 abstract description 12
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 12
- 230000012010 growth Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 241000207929 Scutellaria Species 0.000 abstract description 7
- 230000002708 enhancing effect Effects 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 230000001603 reducing effect Effects 0.000 abstract description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 48
- 230000000694 effects Effects 0.000 description 41
- 230000002354 daily effect Effects 0.000 description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 230000002829 reductive effect Effects 0.000 description 22
- 201000010099 disease Diseases 0.000 description 21
- 230000002401 inhibitory effect Effects 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 206010037660 Pyrexia Diseases 0.000 description 14
- 241000193830 Bacillus <bacterium> Species 0.000 description 12
- 239000003242 anti bacterial agent Substances 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 241001106477 Paeoniaceae Species 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 11
- 208000001848 dysentery Diseases 0.000 description 11
- 230000002265 prevention Effects 0.000 description 11
- 230000029087 digestion Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 235000019786 weight gain Nutrition 0.000 description 10
- 230000004584 weight gain Effects 0.000 description 10
- 230000008030 elimination Effects 0.000 description 9
- 238000003379 elimination reaction Methods 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 208000006673 asthma Diseases 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 241000675108 Citrus tangerina Species 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000002158 endotoxin Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000132012 Atractylodes Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 235000019621 digestibility Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 208000003322 Coinfection Diseases 0.000 description 5
- 241000219784 Sophora Species 0.000 description 5
- 241000191940 Staphylococcus Species 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 229960005486 vaccine Drugs 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 235000010894 Artemisia argyi Nutrition 0.000 description 4
- 206010008631 Cholera Diseases 0.000 description 4
- 241000756943 Codonopsis Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020741 Hyperpyrexia Diseases 0.000 description 4
- 206010020843 Hyperthermia Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 244000030166 artemisia Species 0.000 description 4
- 235000021052 average daily weight gain Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 230000036031 hyperthermia Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 3
- 229940015301 baicalein Drugs 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 208000032625 disorder of ear Diseases 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 206010034829 Pharyngeal oedema Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000223996 Toxoplasma Species 0.000 description 2
- 241001502500 Trichomonadida Species 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- SNEUPKHSXOEPMG-UHFFFAOYSA-N aniline;arsoric acid Chemical compound O[As](O)(O)=O.NC1=CC=CC=C1 SNEUPKHSXOEPMG-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000021051 daily weight gain Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 208000023409 throat pain Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 229940118696 vibrio cholerae Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical group C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N 2-hydroxy-3-propan-2-ylcyclohepta-2,4,6-trien-1-one Chemical compound CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- KQQXUARABJGCMS-UHFFFAOYSA-N 3-methylbutyl 2-hydroxy-2-phenylacetate Chemical group CC(C)CCOC(=O)C(O)C1=CC=CC=C1 KQQXUARABJGCMS-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000029523 Interstitial Lung disease Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 208000001649 Pica Diseases 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 241001673669 Porcine circovirus 2 Species 0.000 description 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 241000725681 Swine influenza virus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241000223997 Toxoplasma gondii Species 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 229960005364 bacitracin zinc Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical group C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000001268 chyle Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 239000010271 massa medicata fermentata Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000006676 mitochondrial damage Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome, belonging to the technical field of feed addictives. The addictive is prepared from Chinese angelica, white paeony root, scutellaria, argy wormwood leaf, rhizoma atractylodis, hawthorn, magnolia officinalis, dried orange peel and liquorice as raw materials according to a certain weight part. By using the functions of enhancing the immunity of pigs, improving the success rate of vaccination and the like, the traditional herbal medicine feed addictive achieves the aims of improving the growth speed of commercial pigs and the conversion rate of the feed, reducing the death rate and the mortality of the pigs and improving economic benefits. The traditional herbal medicine feed addictive can be popularized and applied in pig farmers or farms.
Description
Technical Field
The invention relates to the technical field of feed additives, in particular to a Chinese herbal medicine feed additive with prevention and control effects on swine high fever syndrome and a preparation method thereof.
Background
Porcine hyperthermia syndrome is an infectious disease whose cause is not finally determined, and clinically, sick pigs show high body temperature rise, red skin, respiratory symptoms and digestive symptoms, and high morbidity and mortality. The swinery dies 5-7 days after the disease occurs, and the death gradually subsides after 3 weeks. The incidence rate of the diseases of the swinery is 50-100 percent, and the fatality rate of the diseases is 20-100 percent. In 2006, the swine fever syndrome which occurs in southern provinces at first in China and gradually spreads and spreads to most of swine provinces and regions in China causes huge loss to the swine industry in China, the quantity of stocked swine in some regions with serious epidemic situations is reduced by more than 60%, a plurality of medium and small-sized swine farms are closed due to the high fever syndrome, and the prevalence of the epidemic disease causes death of diseases and culled pigs to reach tens of millions according to estimation of related persons in the industry.
The etiology of porcine high fever syndrome has not been determined to date. From the pathogens detected and separated from sick and dead pigs, porcine reproductive and respiratory syndrome (blue ear disease) virus, porcine circovirus type 2, hog cholera virus, swine influenza virus, porcine pseudorabies virus, escherichia coli, streptococcus suis type 2, salmonella, pasteurella multocida, actinobacillus pleuropneumoniae, haemophilus parasuis, staphylococcus, treponema, toxoplasma gondii, eperythrozoon and the like are involved, and the pathogens are considered to be caused by mixed infection of different combinations of variant strains, bacteria and protozoa of the viruses or the viruses; there is also an epidemiological factor analysis based on which it is believed that an unknown pathogen (virus) is truly an alleged cause.
Because the etiology is unknown, no specific prevention and treatment measures for the swine high fever syndrome exist at present. The method has the main tasks of cutting off all possible spreading sources for a pig farm without epidemic situation, well performing immunization of epidemic diseases such as swine fever and swine enzootic pneumonia, strengthening the feeding management of pigs, increasing the feeding of nutrient additives capable of enhancing the resistance of swinery and well performing the drug prevention and health care of the swinery; for a pig farm with epidemic situation, measures such as disinfection, closing of a pig house with the disease, restriction of flow of raising personnel and the like are enhanced to prevent the spread of the epidemic situation, timely isolation and independent treatment of the sick pigs are needed, and harmless treatment such as deep burying or burning of the pigs dead of the disease is needed to prevent the spread of the pathogen. The vaccine immunization is stopped for the sick pig herd, the antipyretic or antibacterial drug is not needed in the early stage, and the death of the sick pig is accelerated by indiscriminate drug administration. The maintenance measures such as electrolyte and multiple vitamins can be added into drinking water, and after 5-7 days, some symptomatic treatments and antibiotics can be added to control secondary infection.
Through tests, the Chinese herbal medicine feed additive added into the pig feed has a good prevention and control effect on the high fever syndrome of pigs, can reduce the death rate of the herd with epidemic disease by 15 percent (65.2 percent), can improve the growth speed and the feed conversion efficiency of the pigs, and improves the economic benefit.
Disclosure of Invention
Aiming at the pig high fever syndrome, no specific effective prevention and control method exists at present, and a Chinese herbal medicine feed additive with prevention and control effects on the pig high fever syndrome is provided through a compatibility test of compound Chinese herbal medicines, so that various medicines are mutually cooperated to play roles in improving the immunity of the organism, inhibiting or killing probably related pathogeny, and relieving or eliminating various symptoms caused by the high fever syndrome so as to achieve the effect of preventing and controlling the pig high fever syndrome; the invention also aims to provide a preparation method of the Chinese herbal medicine feed additive.
The Chinese herbal medicine feed additive selects Chinese angelica, white paeony root, baical skullcap root, Chinese mugwort leaf, swordlike atractylodes rhizome, hawthorn fruit, officinal magnolia bark, tangerine peel, liquoric root, pilose asiabell root, medicated leaven, Indian buead, sweet wormwood herb, lightyellow sophora root and Chinese pulsatilla root as raw medicinal materials, and is characterized in that:
angelica sinensis can tonify blood, regulate menstruation, promote blood circulation, relieve pain, moisten intestines and relieve constipation. Has effects in nourishing blood, promoting granulation, expelling pus, supporting the interior, moistening intestine and stomach, caring skin, and tonifying blood. Radix Angelicae sinensis contains volatile oil (main component of ligustilide), alkaloid, ferulic acid, radix Angelicae sinensis polysaccharide, fatty oil, nicotinic acid, sucrose, and vitamin B12And trace elements. The angelica can promote the generation of hemoglobin and red blood cells and has the functions of anti-anemia and hematopoiesis; the angelica and the sodium ferulate can inhibit platelet aggregation and have obvious antithrombotic effect, and the angelica has the functions of expanding blood vessels, resisting myocardial ischemia and reducing blood fat. The angelica can also obviously improve the phagocytic capacity of monocytes and abdominal macrophages. Can relax smooth muscle of trachea and has strong spasmolytic effect. Has obvious protective effect on liver damage, liver cell membrane damage and liver mitochondria damage caused by carbon tetrachloride and D-galactosamine, and also has obvious promoting effect on bile secretion. In vitro tests show that radix Angelicae sinensis has inhibitory effect on dysentery bacillus, typhoid bacillus, Escherichia coli, hemolytic streptococcus, etc.
White peony root, radix Paeoniae alba nourishes blood and astringes yin, regulates ying and wei, purges liver and calms spleen. Can be used for treating chest and hypochondrium pain, damp-heat dysentery, and tenesmus abdominal pain. Radix Paeoniae alba contains paeoniflorin, benzoic acid, tannin, volatile oil and paeoniflorin. Has strong inhibiting effect on dysentery bacillus, Escherichia coli, Pseudomonas aeruginosa, staphylococcus, hemolytic streptococcus, Diplococcus pneumoniae, etc. Radix Paeoniae alba also has analgesic and anticonvulsant effects, and can improve tolerance of animal to high temperature stimulation. In addition, the phagocytic function of reticuloendothelial system and the phagocytic function of abdominal macrophage are obviously enhanced; can restore the antibody production of cyclophosphamide-induced hypoimmunity mice to normal level. The white peony root has obvious anti-inflammatory effect, has an inhibiting effect on smooth muscle contraction, has a spasmolytic effect on bronchial smooth muscle spasm during animal asthma attack, and also has an antitussive effect due to bronchiectasis.
Huang Qin clears heat and dries dampness, purges fire and relieves toxicity, especially for clearing lung heat, it is commonly used for cough and dyspnea due to lung heat. Contains baicalin, baicalein, wogonin, and baicalein. Has broad-spectrum antibacterial effect, and can inhibit typhoid bacillus, dysentery bacillus, Pseudomonas aeruginosa, tubercle bacillus, Bordetella pertussis, Vibrio cholerae, staphylococcus, hemolytic streptococcus, meningococcus, influenza virus, dermatophytes, etc. Has antipyretic, tranquilizing, blood pressure lowering, diuretic, animal allergic asthma and skin allergy inhibiting, and capillary permeability reducing effects. Can reduce the lung injury of mice infected with influenza virus and prolong the survival time. Baicalein has antiallergic effect by inhibiting the release of allergic mediator (histamine, chronic reaction substance SRS-A) by inhibiting the prevalence of mercaptoenzyme, and has direct relaxation effect on smooth muscle. It can be used for treating influenza, hyperpyrexia, anicteric hepatitis, pyelonephritis, and viral pneumonia.
Folium Artemisiae Argyi contains volatile oils such as phellandrene, piperylene, thujaplicin, thujaponin, stigmasterol, beta-sitosterol, alpha-resinol, tannin, potassium chloride, vitamin A, D, B, C and choline. The water decoction has different degrees of inhibition effects on staphylococcus aureus, alpha-hemolytic streptococcus, pneumococcus, diphtheria bacillus, dysentery bacillus, typhoid bacillus, paratyphoid bacillus, vibrio cholerae and the like in vitro tests, and has a certain inhibition effect on fungi. The water extract has effects of relaxing guinea pig bronchus, promoting blood coagulation and relieving fever, and promoting urination. It also has therapeutic effect on chronic hepatitis and protozoosis.
Rhizoma atractylodis has the functions of drying dampness and strengthening spleen, and dispelling wind and eliminating dampness and is used for treating abdominal distension, diarrhea and inappetence caused by transport and transformation disorder, can relieve pathogenic wind-cold and can transform damp-turbidity into stagnation, and is the essential product for treating abnormal qi in four seasons. Rhizoma Atractylodis contains volatile oil such as atractylol, atractyl, beta-eucalyptol, etc., and also contains small amount of atractylone and large amount of vitamins A, D and B. It can be used for treating incoordination between spleen and stomach, diarrhea, damp-heat syndrome, dysentery, etc.
Haw is effective in promoting digestion, resolving food stagnation, promoting blood circulation, removing blood stasis, and relieving diarrhea and dysentery. Contains maslinic acid, tartaric acid, citric acid, flavonoids, lactone, saccharides, glycosides, lipolytic enzyme, vitamin C, protein, etc. Has inhibitory effect on various dysentery bacillus and Pseudomonas aeruginosa, and has effects of dilating coronary artery, enhancing myocardial contraction force, slowing heart rate, improving myocardial blood circulation, lowering blood pressure, promoting gastric juice digestive enzyme secretion, and promoting digestion.
The magnolia bark has the functions of promoting qi circulation, eliminating dampness, lowering adverse qi and relieving asthma. It is suitable for treating abdominal distention and abdominal pain due to qi movement disorder, abdominal distention and abdominal pain due to heat accumulation constipation, phlegm retention, cough and asthma. Contains Magnolia officinalis oil, beta-eucalyptol, magnolol, Magnolia obuxonine, tannin, nicotinic acid, etc. Has good inhibitory effect on dysentery bacillus, staphylococcus, amebic protozoa, etc. It is also useful for treating hepatitis B.
Tangerine peel, pericarpium Citri Reticulatae promotes the circulation of qi and strengthens the spleen, eliminates dampness and phlegm. Mainly treats the diseases such as discomfort of spleen and stomach, vomiting, cough, fullness and inappetence, vertigo and the like, contains hesperetin and cis-coumarine, has anti-inflammatory effect, and has obvious anti-ulcer effect on methyl hesperidin. The in vitro test has the effects of inhibiting the growth of staphylococcus, Katanil bacteria and haemophilus hemolyticus. Also contains a large amount of vitamin B1。
Licorice root, radix Glycyrrhizae has the effects of invigorating the middle warmer, replenishing qi, clearing away heat and toxic materials, moistening lung, arresting cough, relieving spasm, alleviating pain, and regulating drug properties. Can be used for treating spleen deficiency, qi deficiency, blood deficiency, heat toxin attacking throat swelling and pain, cough due to lung heat, cough due to lung cold, bladder retention, micturition pain, abdominal spasm pain, stomach cold, abdominal pain, and diarrhea. The Glycyrrhrizae radix contains glycyrrhizin, liquiritin and adrenocorticoid. Has good curative effect on various toxicosis, metabolite poisoning in vivo, tetanus endotoxin, allergic diseases and the like. Has effects in inhibiting smooth muscle activity and relieving intestinal spasm; inhibiting gastric acid secretion, eliminating phlegm, and relieving pain.
Codonopsis pilosula has the effects of tonifying middle-jiao and Qi, enriching blood and promoting fluid production. It is an important herb for deficiency of both qi and blood because it excels in regulating the spleen and stomach. Radix Codonopsis contains saponin, alkaloid, protein, and vitamin B1And B2And glucose and the like. Radix Codonopsis has effects of exciting nervous system, enhancing body resistance, increasing erythrocyte and hemoglobin, and can be used for treating iron deficiency anemia and malnutritional anemia, especially anemia due to digestive absorption dysfunction. The external medicine can eliminate phlegm, invigorate stomach and strengthen metabolism; helping digestion and promoting chyle absorption; increasing blood sugar and promoting blood coagulation. When being matched with angelica, the composition can supplement qi and blood, and further enhance the defense capability of the organism. The codonopsis pilosula stimulates the nervous system to resist the mental depression of the sick pigs;
medicated leaven has the effects of promoting digestion and invigorating stomach, and can be used for treating dyspepsia due to food damage and exogenous pathogenic factors, and diarrhea due to spleen deficiency. The medicated leaven contains lactic acid bacteria, yeast, amylase, volatile oil, glycosides, vitamin B, etc., and has the function of helping digestion of protein, fat and starch.
Poria contains beta-pachyman, triterpenes, ergosterol, protein, fat, lecithin, choline, potassium salt, etc. The ethanol extract of Poria can kill leptospira in vitro. It is combined with Dang Gui and Bai Shao to treat recessive HBV carriers. Therefore, the compound can be used for treating other viral diseases when being matched with the prescription.
Herba Artemisiae Annuae has effects of clearing away heat, relieving summer-heat, cooling blood, removing heat from the blood, and clearing deficiency heat, and contains artemisinin with effects of resisting plasmodium, coccidium, eperythrozoon, toxoplasma, etc., and its alcohol extract has effect of inhibiting leptospira.
Flavescent sophora root has the functions of clearing away heat, drying dampness, dispelling wind, killing parasites and promoting urination. Has inhibiting effect on Staphylococcus aureus, Pseudomonas aeruginosa, dermatophytes, trichomonad, coccidium, etc., and has obvious effect on piglet dysentery.
The Chinese pulsatilla root has the effects of clearing away heat and toxic materials, cooling blood and stopping dysentery, has the effects of inhibiting and killing coccidium, trichomonad, amoeba and other protozoa, and has the treatment effects on bacillary dysentery, mycotic enteritis, ulcerative colitis and the like.
The pathogenesis process of the high fever syndrome is as follows: generally, pigs in the early stage of disease only show increased body temperature, depressed spirit, decreased food intake or loss of appetite, then most pigs are constipation and are spherical, a small amount of sick pigs have diarrhea, yellow and little urine, turbidity and deepened color. The skin of pig is red, the ear edge is cyanosed after the ear, and skin of many parts of the body such as the abdomen and the extremities has purplish red plaques, and the viscera are dissected to show typical septicemia changes. The pigs suffering from dyspnea and lying are partially suffered from severe abdominal respiration and asthma, some pigs are irregularly breathed, and the pigs suffering from rhinorrhea, sneezing, cough and eye secretion increase are suffered from conjunctivitis symptoms. The sick pigs are rapidly thinned, the pigs with a long disease course are pale, the anemia phenomenon appears, the fur is rough, some pigs are yellow-dyed, individual pigs cannot stand before death, and finally the whole pigs die due to convulsion.
The Chinese herbal medicine components of the additive are designed aiming at the clinical symptoms of the swine high fever syndrome: wherein,
radix Codonopsis, radix Angelicae sinensis, radix Paeoniae alba, and Poria all have functions of enhancing immunity and resistance. Particularly, at present, pig farms are originally infected with immune system suppression diseases such as blue-ear diseases, circovirus, swine fever and the like, the overall immune level of the swinery to various infectious diseases is not high, and hidden troubles are buried for outbreak of high fever syndrome. Therefore, improving the resistance of pigs is one of the key measures for preventing such diseases. Scutellariae radix, folium Artemisiae Argyi, and cortex Magnolia officinalis can be used for treating viral diseases such as influenza, hepatitis, and pneumonia, and can also inhibit related viruses. The scutellaria baicalensis, the white paeony root, the folium artemisiae argyi, the hawthorn, the angelica, the dried orange peel and the like have the effect of inhibiting or killing most of gram-positive bacteria and gram-negative bacteria separated from pigs suffering from high fever syndrome. Cortex Magnolia officinalis and folium Artemisiae Argyi have effects of preventing and controlling protozoal diseases. The scutellaria baicalensis clears heat and dampness, purges fire and detoxifies, particularly clears lung heat and treats asthma and cough, and is the symptomatic medicine for treating high fever; the Chinese medicinal composition is also used for treating symptoms of throat swelling and pain, lung heat cough and the like due to congestion or hemorrhage of the larynx and trachea of the pig suffering from high fever and hemorrhagic lung and interstitial pneumonia of the lung. Rhizoma Atractylodis, fructus crataegi, Massa Medicata Fermentata, cortex Magnolia officinalis, pericarpium Citri Tangerinae, and radix Codonopsis can be used for treating anorexia, constipation, and diarrhea and enhancing gastrointestinal digestion function; the folium artemisiae argyi has the effect of treating dysuria, and Chinese herbal medicines such as the angelica sinensis, the folium artemisiae argyi, the rhizoma atractylodis, the hawthorn, the mangnolia officinalis and the like can provide a large amount of vitamins and trace elements to ensure normal operation of body metabolism; the liquorice can neutralize endotoxin generated in metabolism, and can prevent accumulation and poisoning of the endotoxin in sick pigs and death due to the normal digestion, absorption and excretion functions of the sick pigs. In order to enhance the control of parasitic diseases such as pig eperythrozoon, toxoplasma, coccidium and the like, the invention can also add sweet wormwood, radix sophorae flavescentis and Chinese pulsatilla root on the basis of the medicinal materials.
The raw medicinal materials of the invention achieve the comprehensive effect of preventing and controlling the porcine hyperthermia syndrome by the dual functions of inhibiting or killing pathogenic microorganisms and treating various diseases appearing in the porcine hyperthermia syndrome.
The purpose of the invention is realized by the following technical scheme.
The Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of pigs comprises the following raw material medicines in parts by weight: 2-8 parts of angelica sinensis, 2-5 parts of radix paeoniae alba, 8-12 parts of scutellaria baicalensis, 4-6 parts of folium artemisiae argyi, 5-8 parts of rhizoma atractylodis, 8-12 parts of hawthorn, 2-5 parts of mangnolia officinalis, 5-8 parts of pericarpium citri reticulatae and 4-6 parts of liquorice.
The preferred formulation of the additive is: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae and 5 parts of liquorice.
The Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of pigs comprises the following raw material medicines: 2-5 parts of codonopsis pilosula, 8-12 parts of medicated leaven and 3-7 parts of poria cocos.
The preferred formulation of the additive is: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae, 5 parts of liquorice, 3 parts of codonopsis pilosula, 10 parts of medicated leaven and 5 parts of poria cocos.
The Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of pigs comprises the following raw material medicines: 3-7 parts of sweet wormwood, 3-8 parts of radix sophorae flavescentis and 3-8 parts of Chinese pulsatilla root.
The preferred formulation of the additive is: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae, 5 parts of liquorice, 3 parts of codonopsis pilosula, 10 parts of medicated leaven, 5 parts of poria cocos, 5 parts of sweet wormwood, 5 parts of radix sophorae flavescentis and 5 parts of Chinese pulsatilla root.
The preparation method of the Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of the pigs comprises the following steps:
(1) drying and crushing the raw material medicines: drying the raw materials in the sun or in an oven at 60 deg.C; weighing each dry raw material medicine according to a formula; pulverizing the dried raw materials except fructus crataegi and folium Artemisiae Argyi with pulverizer respectively, sieving with 60 mesh sieve, and mixing;
(2) and (3) processing the hawthorn: pulverizing dried fructus crataegi with pulverizer, sieving with 60 mesh sieve, removing hard shell on the sieve, and retaining powder under the sieve;
(3) processing the folium artemisiae argyi: pulverizing dried folium Artemisiae Argyi with pulverizer, and sieving with 60 mesh sieve; decocting the screened large-volume floccules twice with water, wherein the water amount is preferably larger than the medicine surface each time, soaking for 6 hours for the first time, heating and decocting for 30 minutes, and soaking for 2 hours for the second time, and decocting for 30 minutes; cooling each time, squeezing and filtering with 200 mesh nylon screen cloth, mixing extractive solutions, and heating and concentrating to one tenth of original volume; pouring the concentrated solution into sieved folium Artemisiae Argyi powder, stirring, oven drying at 60 deg.C, cooling, and pulverizing into powder;
(4) mixing of the additive: and (3) adding the hawthorn powder in the step (2) and the folium artemisiae argyi powder in the step (3) into the mixed powder in the step (1), and uniformly mixing to obtain the Chinese herbal medicine feed additive.
The application method of the Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of the pigs comprises the following steps: adding the feed in an amount of 0.35%, 0.30% and 0.25% of the weight of the feed respectively in the piglet stage, the pig growth stage and the pig fattening stage, and feeding after uniformly stirring.
The invention has the beneficial effects that:
1. currently, most people consider porcine hyperthermia syndrome to be caused by a mixed infection of viruses, bacteria and protozoa. The feed additive contains broad-spectrum antiviral, antibacterial and antiprotozoal Chinese herbal medicine effective components, and can be used for treating various mixed infection sources of swine high fever syndrome.
2. The feed additive contains a plurality of raw material medicines for enhancing the immunity and the resistance of organisms, can resist the inhibition of an immune system caused by certain viral diseases, reduces secondary infection and improves the survival rate of sick pigs.
3. The feed additive contains the medicines for improving the appetite of animals, promoting digestion and absorption, facilitating excretion and preventing endotoxin poisoning; wherein, the normal appetite and the digestion and absorption functions are maintained, so that the animals can be ensured to take enough nutrition and medicines every day, and the prevention and treatment effects of the medicines are exerted; the normal excretion function is maintained, and the food residues and metabolites can be prevented from being fermented by harmful microorganisms in vivo to generate endotoxin to cause septicemia; the medicine capable of neutralizing endotoxin poisoning has the insurance effect of further eliminating endotoxin.
4. The feed additive contains the medicines for clearing heat, purging fire, detoxifying and treating lung heat cough and asthma, and can be used for resisting the symptoms of body temperature rise, pneumonia and cough and asthma caused by the swine high fever syndrome.
5. The feed additive disclosed by the invention is composed of multiple Chinese herbal medicines rich in vitamins and minerals, and can maintain normal physiological functions, reduce death and accelerate recovery of animals under the condition that electrolytes such as diarrhea and vomiting of pigs are greatly lost.
6. Because the folium artemisiae argyi is large in size after being crushed, the folium artemisiae argyi is difficult to be uniformly mixed with the powder of other raw material medicines, and the palatability is poor, the large-size flocculent oversize product of the crushed folium artemisiae argyi is mixed with other raw materials after the effective components of the crushed folium artemisiae argyi are extracted by water, so that the palatability is improved, the volume of the feed additive is greatly reduced, and the condition that a pig can take enough nutrition and medicines to play the physiological functions of the pig can be ensured.
7. After the Chinese herbal medicine feed additive is used, antibiotics do not need to be added into the feed, so that green and safe pork without the antibiotics can be produced, the drug resistance of microorganisms to the antibiotics can be relieved, the service life of the antibiotics is prolonged, the development cost is reduced, and the prevention and treatment cost of high fever is favorably reduced.
8. After the Chinese herbal medicine feed additive is used, when a pig farm suffers from high fever syndrome of pigs, the Chinese herbal medicine feed additive has the effects of preventing and controlling the disease, can improve the growth speed and the feed conversion efficiency of the pigs, reduce the death rate and the elimination rate of the pigs, reduce the loss caused by diseases and improve the economic benefit of pig raising (see test example 3).
Detailed Description
The Chinese herbal medicine feed additive with prevention and control effect on swine high fever syndrome and the preparation method thereof are further described in detail by the following examples.
Example 1: (Chinese herbal medicine feed additive formula 1)
The formula of the additive comprises the following components: 2kg of angelica, 5kg of white paeony root, 8kg of scutellaria baicalensis, 6kg of folium artemisiae argyi, 5kg of rhizoma atractylodis, 12kg of hawthorn, 2kg of mangnolia officinalis, 8kg of dried orange peel and 4kg of liquorice.
Example 2: (Chinese herbal medicine feed additive formula 2)
The formula of the additive comprises the following components: 5kg of angelica, 3kg of white paeony root, 10kg of scutellaria baicalensis, 5kg of folium artemisiae argyi, 7kg of rhizoma atractylodis, 10kg of hawthorn, 3kg of mangnolia officinalis, 7kg of dried orange peel and 5kg of liquorice.
Example 3: (Chinese herbal medicine feed additive formula 3)
The formula of the additive comprises the following components: 8kg of angelica, 2kg of white paeony root, 12kg of scutellaria baicalensis, 4kg of folium artemisiae argyi, 8kg of rhizoma atractylodis, 8kg of hawthorn, 5kg of mangnolia officinalis, 5kg of dried orange peel and 6kg of liquorice.
Example 4: (Chinese herbal medicine feed additive formula 4)
The formula of the additive is as follows: 8kg of angelica, 2kg of white paeony root, 12kg of baical skullcap root, 4kg of argyi leaf, 8kg of swordlike atractylodes rhizome, 8kg of hawthorn fruit, 5kg of officinal magnolia bark, 5kg of tangerine peel, 6kg of liquoric root, 2kg of pilose asiabell root, 12kg of medicated leaven and 3kg of Indian buead.
Example 5: (Chinese herbal medicine feed additive formula 5)
The formula of the additive is as follows: 5kg of angelica, 3kg of white paeony root, 10kg of baical skullcap root, 5kg of argyi leaf, 7kg of swordlike atractylodes rhizome, 10kg of hawthorn fruit, 3kg of officinal magnolia bark, 7kg of tangerine peel, 5kg of liquoric root, 3kg of pilose asiabell root, 10kg of medicated leaven and 5kg of Indian buead.
Example 6: (Chinese herbal medicine feed additive formula 6)
The formula of the additive is as follows: 2kg of angelica, 5kg of white paeony root, 8kg of scutellaria baicalensis, 6kg of folium artemisiae argyi, 5kg of rhizoma atractylodis, 12kg of hawthorn, 2kg of mangnolia officinalis, 8kg of dried orange peel, 4kg of liquorice, 5kg of codonopsis pilosula, 8kg of medicated leaven and 7kg of poria cocos.
Example 7: (Chinese herbal medicine feed additive formula 7)
The formula of the additive is as follows: 2kg of Chinese angelica, 5kg of white paeony root, 8kg of baical skullcap root, 6kg of Chinese mugwort leaf, 5kg of swordlike atractylodes rhizome, 12kg of hawthorn, 2kg of officinal magnolia bark, 8kg of tangerine peel, 4kg of liquoric root, 5kg of pilose asiabell root, 8kg of medicated leaven, 7kg of Indian buead, 3kg of sweet wormwood herb, 8kg of lightyellow sophora root and 3kg of Chinese pulsatilla root.
Example 8: (Chinese herbal medicine feed additive formula 8)
The formula of the additive is as follows: 5kg of Chinese angelica, 3kg of white paeony root, 10kg of baical skullcap root, 5kg of Chinese mugwort leaf, 7kg of swordlike atractylodes rhizome, 10kg of hawthorn fruit, 3kg of officinal magnolia bark, 7kg of tangerine peel, 5kg of liquoric root, 3kg of pilose asiabell root, 10kg of medicated leaven, 5kg of Indian buead, 5kg of sweet wormwood herb, 5kg of lightyellow sophora root and 5kg of Chinese pulsatilla root.
Example 9: (Chinese herbal medicine feed additive formula 9)
The formula of the additive is as follows: 8kg of Chinese angelica, 2kg of white paeony root, 12kg of baical skullcap root, 4kg of Chinese mugwort leaf, 8kg of swordlike atractylodes rhizome, 8kg of hawthorn fruit, 5kg of officinal magnolia bark, 5kg of tangerine peel, 6kg of liquoric root, 2kg of pilose asiabell root, 12kg of medicated leaven, 3kg of Indian buead, 7kg of sweet wormwood herb, 3kg of lightyellow sophora root and 8kg of Chinese pulsatilla root.
Example 10: (method for preparing additive of examples 1, 2, 3, 4, 5, 6, 7, 8 or 9)
The method comprises the following steps:
(1) drying and crushing the raw material medicines: baking the raw materials in a 60 ℃ oven for 4 hours respectively until the raw materials are dried; weighing the dry raw materials according to the formula; pulverizing the dried raw materials except folium Artemisiae Argyi and fructus crataegi respectively with a pulverizer, sieving with 60 mesh sieve, and mixing;
(2) and (3) processing the hawthorn: pulverizing dried fructus crataegi with pulverizer, sieving with 60 mesh sieve, removing hard shell on the sieve, and retaining powder under the sieve;
(3) processing the folium artemisiae argyi: pulverizing dried folium Artemisiae Argyi with pulverizer, and sieving with 60 mesh sieve; decocting the screened large-volume floccules twice with water, wherein the water amount is preferably larger than the medicine surface each time, soaking for 6 hours for the first time, heating and decocting for 30 minutes, and soaking for 2 hours for the second time, and decocting for 30 minutes; cooling each time, squeezing and filtering with 200 mesh nylon screen cloth, mixing extractive solutions, and heating and concentrating to one tenth of original volume; pouring the concentrated solution into sieved folium Artemisiae Argyi powder, stirring, oven drying at 60 deg.C, cooling, and pulverizing into powder;
(4) mixing of the additive: and (3) adding the hawthorn powder in the step (2) and the folium artemisiae argyi powder in the step (3) into the mixed powder in the step (1), and uniformly mixing in a mixer to obtain the Chinese herbal medicine feed additive.
Test example 1: (comparative tests of different feed additives on pig growth and feed conversion rates)
40 weaned piglets with the weight of about 10kg are selected, the number of the weaned piglets is 4 for each half of the weaned piglets and 2 for each group. The control group was fed with antibiotics and the test group was fed with the Chinese herbal medicine feed additive and the compound feed according to the formula of example 2 at a ratio of 0.35% (no antibiotics were added to the feed). As a result: the daily gain of the piglet stage test group and the piglet stage control group are 433 +/-173 g and 371 +/-154 g respectively, the feed weight ratio is 2.00 and 2.31 respectively, the daily gain of the test group is increased by 16.7 percent compared with the piglet stage control group, and the feed weight ratio is reduced by 13.4 percent; the daily gain of the test group and the control group in the growing pig stage is 548 +/-71 g and 474 +/-87 g respectively, the feed-weight ratio is 2.50 and 2.82 respectively, the daily gain of the test group is increased by 15.6 percent compared with the control group, and the feed-weight ratio is reduced by 11.3 percent. Tests prove that the Chinese herbal medicine feed additive has better growth promoting effect and feed reward improving effect by replacing antibiotics.
Test example 2: (comparative tests of different feed additives on pig mortality, elimination rate, feed-to-weight ratio and digestibility)
400 weaned piglets weighing about 14kg were picked and randomly divided into 4 groups of 10 columns with 10 pigs in each group and pigs in 4 groups randomly distributed in 2 piggeries. Feeding antibiotic + compound feed (the antibiotic used in the feed in the piglet stage is sulfuric acid antibiotics + bacitracin zinc + p-aminobenzene arsenic acid, and the antibiotic used in the growing pig and fattening pig stage is aureomycin + p-aminobenzene arsenic acid); group 2 was fed with the herbal feed additive + compound feed (0.35% in piglet stage feed and 0.30% in growing pig stage feed) of the formula of example 2; feeding the group 3 with the feed additive containing the Chinese herbal medicines prepared in example 3 in the same amount as the group 2; group 4 was fed the same feed supplement containing the herbal composition prepared in example 4 in the same amount as in group 2. The basic formulas of the daily rations of 4 groups are the same, 3 groups using the Chinese herbal medicine feed additive do not contain any antibiotic, and other daily production management is the same as that of a pig farm production group.
Approximately 1 month after the start of the trial, the pig farm was attacked by swine high fever syndrome, and the trial house was also infected. As a result, 23 pigs in group 1, the antibiotic control group, died with a mortality rate of 23%; group 2, group 3 and group 4 died 9, 8, 9 respectively, with mortality rates of 9%, 8% and 9%, respectively. The two percentage data were tested for significant difference, with group 2 and group 4 being significantly different from the control (P < 0.05), and group 3 being significantly different from the control (P < 0.01). The application of the Chinese herbal medicine feed additive of the invention can obviously reduce the death rate of the swinery affected by the hyperpyrexia syndrome. Some pigs suffering from high fever syndrome are eliminated as dead pigs without death through rescue and treatment, and the eliminated pigs of the 1 st group to the 4 th group have 11 heads, 4 heads, 2 heads and 3 heads respectively. Through statistical test, the elimination rate of the group 3 and the group 4 is obviously lower than that of the control group (P is less than 0.05), and the difference between the group 2 and the control group is not obvious (P is more than 0.05). If the Chinese herbal medicine feed additives are combined and calculated, the elimination rate of the Chinese herbal medicine feed additive group is extremely lower than that of an antibiotic control group (P is less than 0.01), so the number of eliminated pigs caused by high fever syndrome can be obviously reduced after the Chinese herbal medicine feed additive is applied.
At the beginning of the test, the average body weights of the pigs in groups 1 to 4 were 14.2 + -3.2, 13.7 + -3.1, 13.5 + -1.9 and 13.8 + -2.8 kg, respectively. The average weight of each group (no culled pig is added) at the end of the piglet stage is respectively 30.8 +/-5.0, 31.9 +/-4.9, 31.8 +/-4.8 and 31.7 +/-5.1 kg, the average daily weight gain is respectively 346, 377, 381 and 373g, and the daily weight gain of the Chinese herbal medicine feed additive group is obviously higher than that of the control group (P is less than 0.05). By the end of the growing pig stage, the average body weight of each group (excluded pigs) was 64.7 + -10.6, 67.3 + -10.6, 67.7 + -10.5 and 67.0 + -10.8 kg, and the daily gain was 611, 632, 634 and 630 g. Differences between groups in daily gain were not significant (P > 0.05). The feed weight ratio of each group is respectively 2.32, 2.20, 2.19 and 2.22 in the piglet stage and is respectively 2.63, 2.51, 2.49 and 2.51 in the growing pig stage, the feed consumption of each kilogram of weight gain is lower, and the Chinese herbal medicine feed additive group is lower than the antibiotic control group. In general, the growth rate and feed return of pigs using the herbal feed additive were higher than those of the control group using antibiotics.
When the test was performed for about 100 days, feed samples of pigs in groups 1 and 3 and fecal samples of pigs were collected, and digestion test was performed by 4N HCl insoluble ash method, and as a result, the digestibility of dry matter, crude protein, crude fat, crude fiber, crude ash, and nitrogen-free extract in groups 1 and 3 (herbal additive group 2) was (93.3 ± 1.5%), 94.9 ± 0.9%, (93.3 ± 1.3%), 94.4 ± 1.2%, (73.2 ± 5.7%), 79.0 ± 3.3%, (76.9 ± 5.2),% (82.8 ± 3.5%), 73.2 ± 5.7%, (78.8 ± 3.3%, (97.4 ± 0.7%) and (98.2 ± 0.4%), and the digestibility of the feed additive group was improved by 1.7%, and 7% respectively. From the above data, the nutrient with lower digestibility is improved to a greater extent, which indicates that the Chinese herbal medicine feed additive of the invention has the function of improving the pig digestibility.
In conclusion, the Chinese herbal medicine feed additive has a prevention and control effect on the hyperpyrexia syndrome of pigs, can obviously reduce the death and culling rate of the pigs suffering from hyperpyrexia, improves the weight gain speed, the digestibility of nutrient substances and improves the feed reward; and the Chinese herbal medicine feed additive is a pure natural substance, has no potential safety and residue problems like using antibiotics, and has wide application prospect.
Test example 3: (comparative test of different feed additives on pig productivity, economic benefit and immunity)
90 weaned piglets with the weight of about 8kg are selected, divided into 9 columns and 10 pigs in each column, and randomly divided into 3 groups, and each group comprises 30 pigs. The formal test was started after the pigs were tested for 10 days without abnormality. Wherein, one group (Chinese herbal medicine group) is fed with the Chinese herbal medicine feed additive (prepared by the formula of the example 5), the other group is fed with the plant extract additive (high-benefit group) produced by the biological technology limited company of Yingguorekang (Guangzhou), and the other group is only the compound feed (control group) self-prepared in the test pig farm. Wherein the Chinese herbal medicine feed is prepared by respectively adding 0.35%, 0.30% and 0.25% of Chinese herbal medicine feed additives into piglets, growing pigs and fattening pigs on the basis of the control group feed. The high-goodness high-group feed is prepared by respectively adding 0.08%, 0.06% and 0.05% of high-goodness high-additives on the basis of the control group feed. The three groups of the feed management measures are the same except for different additives. The production performance, mortality and elimination rate of the pigs of each treatment group were observed. 12 pigs were collected before the start of the test and at a weight of about 60kg per group to analyze the immune index, and swine fever antibodies were detected by collecting blood 29 days after inoculation of swine fever vaccine.
When the piglet stage test is started, the average body weight of each group is similar, and when the stage test is ended, the average body weight is sequentially a control group, a Chinese herbal medicine group and a high-benefit group from high to low, and the average daily feed intake, the average daily gain and the feed conversion efficiency are consistent in sequence, but the difference is very small (P is more than 0.05). The daily gain of the Chinese herbal medicine is 4.0 percent lower than that of the control group, and the feed consumption of unit gain is 1.8 percent higher; the daily gain of the Chinese herbal medicine is 1.9 percent higher than that of a good group, and the feed consumption of unit gain is 0.6 percent lower than that of a good group.
The results of the tests, the productivity of the pigs are shown in Table 1.
TABLE 1 comparison of Productivity of pigs tested in each group
Note: initial average body weights at the growing and finishing stages did not include body weights of dead or culled pigs at this stage.
In the growing stage of pigs, the average daily weight gain of the Chinese herbal medicine is 7.9 percent higher than that of a control group, and the feed consumption of unit weight gain is reduced by 8.4 percent compared with that of the control group; compared with the good group, the daily gain of the two groups is very close (99.96%), and the feed consumption of the unit gain is reduced by 4.3%. The daily gain of the high-performance group is increased by 7.9 percent compared with that of a control group, the feed consumption of unit weight gain is reduced by 4.3 percent, and the high-performance group also shows certain effects of promoting growth and improving the feed efficiency. At this stage, the average daily food intake of the Chinese herbal medicine group was the lowest, 1.2% and 4.3% lower than the control group and the good high group, respectively, but the comprehensive productivity was the highest among the three groups.
In the stage of fattening pigs, the average daily weight gain of the Chinese herbal medicines is 2.1 percent higher than that of a control group, the average daily feed intake is reduced by 5.1 percent, and the feed consumption of unit weight gain is reduced by 7.0 percent compared with that of the control group; compared with the Haoyao group, the daily gain is improved by 5.9 percent, the average daily feed intake is reduced by 7.2 percent, and the feed consumption of unit weight gain is reduced by 11.4 percent. The daily gain of the high-benefit group is 3.6 percent lower than that of the control group, the average daily feed intake is improved by 2.3 percent, the feed consumption of unit weight gain is reduced by 5.0 percent, and the comprehensive production performance of the high-benefit group is inferior to that of the control group.
In the whole test period, the average daily weight gain of the Chinese herbal medicine is respectively increased by 2.9 percent and 0.6 percent compared with the control group and the high-benefit group, the feed consumption of unit weight gain is respectively reduced by 5.7 percent and 5.4 percent, but the difference is not obvious (P is more than 0.05). From the test results, the Chinese herbal medicine feed additive has the tendency of improving the daily weight gain and the feed utilization rate of pigs.
The number of dead and culled pigs in each stage of the trial for the three groups is shown in table 2. During the test period, 3 pigs died in the control group, and 3 pigs were rejected due to the diseased cad; 1 pig died from the Chinese herbal medicine group, and 2 pigs were rejected; the high pigs died 4 and 3 were rejected. Compared with a control group and a good group, the Chinese herbal medicine has the mortality rate reduced by 66.7 percent and 75 percent, and the elimination rate is reduced by 33.3 percent and 33.3 percent. The Chinese herbal medicine pig has ruddy skin and bright hair color, and has certain health care and disease prevention effects.
TABLE 2 number of dead and culled pigs at different stages of the test for each group (head)
According to the method, the prices of market piglets and fat pigs are 12.8 yuan/kg at the end of the test, the prices of piglet feed, growing pig feed and fattening pig feed during the test are respectively 2.83 yuan/kg, 2.55 yuan/kg and 2.36 yuan/kg, the prices of Chinese herbal medicine feed additive and the high-yield additive are respectively 36 yuan/kg and 100 yuan/kg, the prices of piglet feed, growing pig feed and fattening pig feed of the Chinese herbal medicine are calculated according to the using amount of the additive and are respectively 2.956 yuan/kg, 2.658 yuan/kg and 2.45 yuan/kg, the prices of piglet feed, growing pig feed and fattening pig feed of the high-yield group are respectively 2.91 yuan/kg, 2.61 yuan/kg and 2.41 yuan/kg, the hair profit after the piglet cost and the feed cost are deducted from the Chinese herbal medicine feed group is calculated is increased by 2916.84 yuan compared with that of the control group, and is increased by 4913.97 yuan compared with that of the high-yield group. That is, the amount of the Chinese herbal medicine in each pig is more than 97.23 yuan in comparison with the control group and more than 163.80 yuan in comparison with the benefit group. The economic benefit obtained by adding Chinese herbal medicines is very obvious.
The immune index and the detection result of the swine fever antibody are shown in Table 3.
TABLE 3 immune index and swine fever antibody test results of each treatment group
Detecting items | Chinese herbal medicine | High group of great benefit | Control group |
α-IFN(pg/ml) | 36.63±20.6 | 35.92±15.41 | 40.16±14.50 |
IL-2(ng/ml) | 6.41±3.58 | 5.17±2.40 | 7.05±3.52 |
CD4(u/ml) | 6.72±2.20 | 6.57±1.29 | 6.44±1.49 |
CD3(u/ml) | 7.62±8.91 | 5.42±2.77 | 5.27±5.01 |
CD8(u/ml) | 27.47±44.07 | 12.79±8.37 | 18.58±32.87 |
C3(μg/ml) | 19.34±17.74 | 12.14±6.38 | 8.39±8.38 |
C4(μg/ml) | 1.14±1.55 | 0.71±0.34 | 0.80±0.70 |
IgA(g/l) | 0.89±0.22 | 0.72±0.17 | 0.78±0.23 |
IgM(g/l) | 1.23±1.16 | 1.15±0.33 | 1.22±0.33 |
Detecting items | Chinese herbal medicine | High group of great benefit | Control group |
IgG(g/l) | 8.00±1.86 | 6.79±2.50 | 9.13±1.91 |
Antibody positive for hog cholera | 10/12 | 5/12 | 5/12 |
As can be seen from Table 3, the other 7 index Chinese herbal medicines except for alpha-IFN, IL-2 and IgG are all higher than the control group; all immunity index values were higher than those in the good high group. Jingchi type2The test shows that the Chinese herbal medicine feed additive has very obvious effect (P is less than 0.005) on improving the generation of the antibody of the swine fever vaccine. Illustrating the Chinese herbal medicine feed additive of the inventionHas certain function of improving the immunity of the organism.
Experimental example 4: (comparative tests of different feed additives on pig Productivity, Swine fever antibody and pathogen detection)
Selecting 60 weaned piglets with similar weight and age of day, and dividing into 6 rows, 3 rows in each group, and 30 pigs. A control group feeding field self-prepared compound feed is added into a test group, the Chinese herbal medicine feed additive (0.35 percent in piglet feed, 0.30 percent in growing pig feed and 0.25 percent in fattening pig feed) with the formula in the embodiment 8 is added into the control group feed, the production performance of pigs is observed, 4 pigs are extracted for blood sampling to detect swine fever antibodies 29 days after inoculation of swine fever vaccines, 4 pigs are extracted for blood sampling before and 5 months after the test, RNA is extracted, and the pathogeny of blue ear disease (PRRS) and Japanese encephalitis (JBE) is analyzed by an RT-PCR method.
The production performance of pigs fed with the herbal feed additive of the invention was compared with that of the control group as shown in Table 4.
Table 4 experimental example 4 comparison of the productivity of differently treated pigs
Item | Chinese herbal medicine | Control group | Comparison of |
Mean body weight (kg) at the beginning of the test | 11.98±1.68 | 12.26±1.49 | 97.72 |
Average weight (kg) at piglet end | 49.91±4.82 | 50.62±5.62 | 98.60 |
Average weight (kg) at the end of growing pigs | 75.89±7.98 | 73.43±9.09 | 103.35 |
Average weight (kg) at finishing of fattening pig | 110.81±10.21 | 107.17±10.25 | 103.40 |
Average daily gain (g) of piglets | 621.8±70.9 | 628.9±85.0 | 98.87 |
Average daily gain (g) of growing pig | 742.3±140.5 | 677.5±122.5 | 109.56 |
Average daily gain (g) of fattening pig | 812.1±128.5 | 762.7±211.9 | 106.48 |
Average daily gain (g) over the whole period | 711.0±73.6 | 683.1±73.4 | 104.08 |
Piglet stage feed weight ratio | 2.22±0.19 | 2.23±0.15 | 99.34 |
Feed-to-weight ratio in growing pig stage | 3.01±0.05 | 3.33±0.19 | 90.27 |
Feed weight ratio of fattening pig stage | 3.89±0.21 | 4.61±0.18 | 84.51 |
Item | Chinese herbal medicine | Control group | Comparison of |
At the whole stageMaterial to weight ratio | 2.97 | 3.25 | 91.38 |
Total consumptive material (kg) | 7973.26 | 8217.05 | 97.03 |
Total weight gain (kg) | 2682.46 | 2530.83 | 105.99 |
Although the daily gain of the fed Chinese herbal medicine pig is 1.4 percent lower than that of a control group in a piglet stage, the daily gain of the fed Chinese herbal medicine pig is respectively increased by 9.56 percent and 6.48 percent compared with that of the control group in a growing stage and a fattening stage, the average daily gain of the whole stage is increased by 4.1 percent, the feed consumed by each kilogram of weight gain is respectively reduced by 0.6 percent, 9.7 percent and 15.5 percent in the piglet stage, the growing stage and the fattening stage, and the whole stage is reduced by 8.6 percent.
The results of the detection of the hog cholera antibodies and the pathogen are shown in Table 5.
TABLE 5 hog cholera antibody and pathogen detection results of Chinese herbal medicine and control group pigs
Item | Chinese herbal medicine | ControlGroup of |
Hog cholera antibody (negative number/detection number) | 1/12 | 4/12 |
PRRS pathogen positivity (number of positives/number of detections) | 12/12 | 12/12 |
JBE pathogen positivity (number of positive/number of test) | 0/12 | 1/12 |
The detection shows that the vaccine inoculation failure (swine fever antibody negative) of swine fever is 1 in the Chinese herbal medicine, 4 in the control group and chi2The difference is significant (P < 0.05) by inspection. The porcine reproductive and respiratory syndrome virus was positive in both groups because the pigs were vaccinated against porcine reproductive and respiratory syndrome. The encephalitis B virus is negative before the test is started, the Chinese herbal medicine group still keeps negative after the spot check 5 months after the test is started, and the control group has 1 positive, so that the Chinese herbal medicine is presumed to have a certain prevention effect on epidemic encephalitis B.
Test example 5: (comparison test of pig productivity, mortality and elimination rate with different feed additives)
120 weaned piglets with the weight of about 10kg and the age of day close to each other are selected, the weaned piglets are divided into 8 groups, 15 pigs in each group are randomly divided into 2 groups, 4 pigs in each group and 60 pigs in each group, and two adjacent pigs in the same group share one trough. The control group feeding farm self-prepared compound feed, the Chinese herbal medicine test group added the Chinese herbal medicine feed additive prepared according to the formula of example 5 (0.35% in the piglet feed, 0.30% in the growing pig feed and 0.25% in the fattening pig feed) on the basis of the control group feed, the production performance of the pigs was examined, and the number of dead pigs and the number of rejected pigs were recorded. The results are shown in Table 6.
TABLE 6 test results of pig productivity, mortality and culling
Item | Chinese herbal medicine | Control group |
Average daily gain (g) in piglet stage | 527.9±87.5 | 492.8±88.6g |
Average daily gain (g) in growing pig stage | 668.2±165.5 | 651.4±137.6 |
Item | Chinese herbal medicine | Control group |
Average daily gain (g) over the whole period | 603.5±89.2 | 582.3±100.5 |
Piglet stage feed weight ratio | 1.65 | 1.75 |
Feed-to-weight ratio in growing pig stage | 1.79 | 1.85 |
Material to weight ratio at full stage | 1.82 | 1.73 |
Pig mortality (%) | 0 | 1.7 |
Pig culling rate (%) | 0 | 1.7 |
Number of pigs biting into tail (head) | 5 | 10 |
In the piglet stage, the daily gain of the Chinese herbal medicine pig is increased by 7.2 percent compared with that of a control group, and the daily gain of the growing pig is increased by 2.6 percent; the Chinese herbal medicines are saved by 5.9 percent and 3.6 percent respectively compared with the control group when the weight of each kilogram of the feed is increased; the Chinese herbal medicine for the whole-period daily gain is improved by 3.6 percent compared with the control group, and the feed consumption of each kilogram of gain is reduced by 4.6 percent. The Chinese herbal medicine group has no pig death or elimination in the test period, and the pig death rate and elimination rate are reduced by 1.7 percent compared with those of a control group. The number of pigs with tail biting is half less than that of the control group.
From the test examples, the Chinese herbal medicine feed additive has the effects of preventing and controlling the high fever syndrome of the pigs, improving the growth speed, the feed utilization efficiency and the economic benefit of the pigs, improving the organism immunity of the pigs, reducing the allotriophagy of the pigs and the like.
Claims (7)
1. The Chinese herbal medicine feed additive for preventing and controlling the high fever syndrome of pigs is characterized in that the raw material medicines of the additive and the raw material medicines are in parts by weight: 2-8 parts of angelica sinensis, 2-5 parts of radix paeoniae alba, 8-12 parts of scutellaria baicalensis, 4-6 parts of folium artemisiae argyi, 5-8 parts of rhizoma atractylodis, 8-12 parts of hawthorn, 2-5 parts of mangnolia officinalis, 5-8 parts of pericarpium citri reticulatae and 4-6 parts of liquorice.
2. The additive as claimed in claim 1, wherein the raw material medicine of the additive comprises the following raw material medicines in parts by weight: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae and 5 parts of liquorice.
3. The additive as claimed in claim 1, wherein the additive comprises the following raw material herbs in parts by weight: 2-5 parts of codonopsis pilosula, 8-12 parts of medicated leaven and 3-7 parts of poria cocos.
4. The additive as claimed in claim 3, wherein the raw material medicine of the additive comprises the following raw material medicines in parts by weight: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae, 5 parts of liquorice, 3 parts of codonopsis pilosula, 10 parts of medicated leaven and 5 parts of poria cocos.
5. The additive as claimed in claim 3, wherein the additive comprises the following raw material herbs in parts by weight: 3-7 parts of sweet wormwood, 3-8 parts of radix sophorae flavescentis and 3-8 parts of Chinese pulsatilla root.
6. The additive as claimed in claim 5, wherein the raw material medicine of the additive comprises the following raw material medicines in parts by weight: 5 parts of angelica, 3 parts of white peony root, 10 parts of scutellaria baicalensis, 5 parts of folium artemisiae argyi, 7 parts of rhizoma atractylodis, 10 parts of hawthorn, 3 parts of mangnolia officinalis, 7 parts of pericarpium citri reticulatae, 5 parts of liquorice, 3 parts of codonopsis pilosula, 10 parts of medicated leaven, 5 parts of poria cocos, 5 parts of sweet wormwood, 5 parts of radix sophorae flavescentis and 5 parts of Chinese pulsatilla root.
7. A process for the preparation of the additive according to claim 1, 2, 3, 4, 5 or 6, characterized in that it is carried out by the following steps:
(1) drying and crushing the raw material medicines: drying the raw materials in the sun or in an oven at 60 deg.C; weighing each dry raw material medicine according to a formula; pulverizing the dried raw materials except fructus crataegi and folium Artemisiae Argyi with pulverizer respectively, sieving with 60 mesh sieve, and mixing;
(2) and (3) processing the hawthorn: pulverizing dried fructus crataegi with pulverizer, sieving with 60 mesh sieve, removing hard shell on the sieve, and retaining powder under the sieve;
(3) processing the folium artemisiae argyi: pulverizing dried folium Artemisiae Argyi with pulverizer, and sieving with 60 mesh sieve; decocting the screened large-volume floccules twice with water, wherein the water amount is preferably larger than the medicine surface each time, soaking for 6 hours for the first time, heating and decocting for 30 minutes, and soaking for 2 hours for the second time, and decocting for 30 minutes; cooling each time, squeezing and filtering with 200 mesh nylon screen cloth, mixing extractive solutions, and heating and concentrating to one tenth of original volume; pouring the concentrated solution into sieved folium Artemisiae Argyi powder, stirring, oven drying at 60 deg.C, cooling, and pulverizing into powder;
(4) mixing of the additive: and (3) adding the hawthorn powder in the step (2) and the folium artemisiae argyi powder in the step (3) into the mixed powder in the step (1), and uniformly mixing to obtain the Chinese herbal medicine feed additive.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101946648A CN101869220B (en) | 2010-06-07 | 2010-06-07 | Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101946648A CN101869220B (en) | 2010-06-07 | 2010-06-07 | Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101869220A true CN101869220A (en) | 2010-10-27 |
CN101869220B CN101869220B (en) | 2012-06-13 |
Family
ID=42994450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101946648A Expired - Fee Related CN101869220B (en) | 2010-06-07 | 2010-06-07 | Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101869220B (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103783311A (en) * | 2012-11-05 | 2014-05-14 | 天津市中敖饲料有限公司 | Feed additive with effects of improving immunity and pork quality and preparation method for feed additive |
CN103859225A (en) * | 2014-03-21 | 2014-06-18 | 安徽泗县成安牧业科技有限公司 | Pig-immunity-improving feed and preparation method thereof |
CN104173628A (en) * | 2014-08-11 | 2014-12-03 | 宾阳县王灵镇良骏养鹅场 | Traditional Chinese medicine composition for resisting pig immunosuppression |
CN104171635A (en) * | 2014-07-21 | 2014-12-03 | 宁国市百惠牧业有限公司 | Chinese herbal medicine diet pig feed capable of helping digestion |
CN104324268A (en) * | 2014-11-13 | 2015-02-04 | 烟台大木医药技术有限公司 | Feed additive for preventing and treating swine high fever syndrome |
CN104922626A (en) * | 2015-05-27 | 2015-09-23 | 山东迅达康兽药有限公司 | Traditional Chinese medicine composition for treating porcine eperythrozoonosis and preparation method thereof |
CN105166458A (en) * | 2015-08-07 | 2015-12-23 | 淮安正昌饲料有限公司 | Fermented selenium-rich plant feed additive resistant to pig heat stress |
CN105166459A (en) * | 2015-08-07 | 2015-12-23 | 淮安正昌饲料有限公司 | Pig feed |
CN106260642A (en) * | 2016-08-15 | 2017-01-04 | 王东平 | A kind of lactobacillus feed additive preventing and treating swine fever and its preparation method and application |
CN106615776A (en) * | 2016-11-16 | 2017-05-10 | 临沂大学 | Anti-mycotoxin feed additive for pigs as well as preparation method and application of anti-mycotoxin feed additive |
CN106615852A (en) * | 2017-01-19 | 2017-05-10 | 陆川县三农畜牧服务有限公司 | Fermented feed for pig and preparation method of fermented feed |
CN108967657A (en) * | 2018-05-24 | 2018-12-11 | 江口县旭辉生态农业科技有限公司 | A kind of diet agent and preparation method thereof |
CN109006666A (en) * | 2018-07-14 | 2018-12-18 | 句容茅山宝地黑香猪专业合作社 | A kind of method for culturing pigs of antibiotic-free and additive |
CN111296639A (en) * | 2020-03-30 | 2020-06-19 | 河南科技学院 | High-temperature stress resistant Chinese herbal medicine feed additive for pigs, preparation method thereof and high-temperature stress resistant pig feed |
CN113813345A (en) * | 2021-10-12 | 2021-12-21 | 吴晓林 | Fermented traditional Chinese medicine preparation for improving health vitality of young livestock and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167918A (en) * | 2007-10-25 | 2008-04-30 | 杨成全 | Traditional Chinese medicinal preparation for increasing immunity of pig or poultry |
CN101342362A (en) * | 2008-08-27 | 2009-01-14 | 赵记章 | Traditional Chinese medicine for treating blue-ear pig disease |
CN101695342A (en) * | 2009-10-23 | 2010-04-21 | 孟祥合 | Chinese herbal medicinal feed additive for preventing and controlling swine infectious disease |
-
2010
- 2010-06-07 CN CN2010101946648A patent/CN101869220B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167918A (en) * | 2007-10-25 | 2008-04-30 | 杨成全 | Traditional Chinese medicinal preparation for increasing immunity of pig or poultry |
CN101342362A (en) * | 2008-08-27 | 2009-01-14 | 赵记章 | Traditional Chinese medicine for treating blue-ear pig disease |
CN101695342A (en) * | 2009-10-23 | 2010-04-21 | 孟祥合 | Chinese herbal medicinal feed additive for preventing and controlling swine infectious disease |
Non-Patent Citations (1)
Title |
---|
《畜禽业》 20091130 黄清等 中西药结合防治猪高热综合症的疗效观察 , 第247期 2 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103783311A (en) * | 2012-11-05 | 2014-05-14 | 天津市中敖饲料有限公司 | Feed additive with effects of improving immunity and pork quality and preparation method for feed additive |
CN103859225A (en) * | 2014-03-21 | 2014-06-18 | 安徽泗县成安牧业科技有限公司 | Pig-immunity-improving feed and preparation method thereof |
CN103859225B (en) * | 2014-03-21 | 2015-05-20 | 安徽泗县成安牧业科技有限公司 | Pig-immunity-improving feed and preparation method thereof |
CN104171635A (en) * | 2014-07-21 | 2014-12-03 | 宁国市百惠牧业有限公司 | Chinese herbal medicine diet pig feed capable of helping digestion |
CN104173628B (en) * | 2014-08-11 | 2017-10-27 | 宾阳县王灵镇良骏养鹅场 | A kind of immunosuppressive Chinese medicine composition of anti-pig |
CN104173628A (en) * | 2014-08-11 | 2014-12-03 | 宾阳县王灵镇良骏养鹅场 | Traditional Chinese medicine composition for resisting pig immunosuppression |
CN104324268A (en) * | 2014-11-13 | 2015-02-04 | 烟台大木医药技术有限公司 | Feed additive for preventing and treating swine high fever syndrome |
CN104922626A (en) * | 2015-05-27 | 2015-09-23 | 山东迅达康兽药有限公司 | Traditional Chinese medicine composition for treating porcine eperythrozoonosis and preparation method thereof |
CN105166458A (en) * | 2015-08-07 | 2015-12-23 | 淮安正昌饲料有限公司 | Fermented selenium-rich plant feed additive resistant to pig heat stress |
CN105166459A (en) * | 2015-08-07 | 2015-12-23 | 淮安正昌饲料有限公司 | Pig feed |
CN106260642A (en) * | 2016-08-15 | 2017-01-04 | 王东平 | A kind of lactobacillus feed additive preventing and treating swine fever and its preparation method and application |
CN106615776A (en) * | 2016-11-16 | 2017-05-10 | 临沂大学 | Anti-mycotoxin feed additive for pigs as well as preparation method and application of anti-mycotoxin feed additive |
CN106615852A (en) * | 2017-01-19 | 2017-05-10 | 陆川县三农畜牧服务有限公司 | Fermented feed for pig and preparation method of fermented feed |
CN108967657A (en) * | 2018-05-24 | 2018-12-11 | 江口县旭辉生态农业科技有限公司 | A kind of diet agent and preparation method thereof |
CN109006666A (en) * | 2018-07-14 | 2018-12-18 | 句容茅山宝地黑香猪专业合作社 | A kind of method for culturing pigs of antibiotic-free and additive |
CN111296639A (en) * | 2020-03-30 | 2020-06-19 | 河南科技学院 | High-temperature stress resistant Chinese herbal medicine feed additive for pigs, preparation method thereof and high-temperature stress resistant pig feed |
CN113813345A (en) * | 2021-10-12 | 2021-12-21 | 吴晓林 | Fermented traditional Chinese medicine preparation for improving health vitality of young livestock and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101869220B (en) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101869220B (en) | Traditional herbal medicine feed addictive for preventing and controlling swine high fever syndrome | |
CN104256168B (en) | One boar functional feed and preparation method thereof | |
CN103212006A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
CN102178100A (en) | Low-tryptophan feed for hybrid chicken and preparation method of the low-tryptophan feed | |
CN115350242B (en) | Glycolipid metabolism regulator and preparation method and application thereof | |
CN105497224A (en) | Anti-viral traditional Chinese medicine micro-ecological preparation for livestock and poultry and preparation method of anti-viral traditional Chinese medicine micro-ecological preparation | |
CN103585433A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN102872392B (en) | Chinese medicinal preparation for preventing and controlling swine mycoplasma pneumonia and preparation method thereof | |
CN102319297B (en) | Traditional Chinese veterinary medicine used for treating livestock, poultry and fish diseases | |
CN102805774B (en) | Chinese medicinal superfine powder for improving organism immunity of livestock and poultry and preparation method thereof | |
CN102846864B (en) | Chinese herbal veterinary medicine for preventing and treating swine infectious atrophic rhinitis and preparation process thereof | |
CN102058810B (en) | Lung-clearing asthma-relieving phlegm-reducing Chinese patent drug | |
CN102872321B (en) | Chinese medicinal preparation for preventing and controlling porcine reproductive and respiratory syndrome and preparation method thereof | |
CN104383288A (en) | Pharmaceutical composition for treating bovine pneumonia and preparation method of pharmaceutical composition for treating bovine pneumonia | |
CN115969909B (en) | Traditional Chinese medicine composition and fermented traditional Chinese medicine preparation for improving sub-health of sow as well as preparation method and application of traditional Chinese medicine composition and fermented traditional Chinese medicine preparation | |
CN103977372A (en) | Traditional Chinese medicine additive used for treating porcine epizootic diarrhea and preparing method thereof | |
CN104189231B (en) | A kind of for the antiviral Chinese medicine preparation and its preparation method that strengthen immunity | |
CN111588801B (en) | Traditional Chinese medicine dispersible granule for preventing livestock and poultry epidemic diseases and preparation method thereof | |
CN109432287B (en) | Traditional Chinese medicine oral liquid for preventing and treating excessive heat syndrome of poultry qi system and preparation method thereof | |
CN109646546B (en) | A Chinese medicinal composition for preventing and treating diarrhea of livestock, and its preparation method | |
CN105327147A (en) | Medicine composition for treating swine enzootic pneumonia and preparation method thereof | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN101085048B (en) | Traditional Chinese medicine for detoxicating for animals and preparation method thereof | |
CN104288722A (en) | Pharmaceutical composition for treating infectious pleuropneumonia of swine and preparation method thereof | |
CN115887572B (en) | Preparation method and application of compound traditional Chinese medicine soluble powder for preventing and treating pig reproduction and respiratory syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120613 Termination date: 20130607 |